Rocky Mountain Cancer Centers is a clinical research site located in Lone Tree, Colorado, United States 80124.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers has participated in 26 clinical trials with 10 currently active.
Therapeutic areas: Metastatic Renal Cell Carcinoma, Breast Cancer, Metastatic Breast Cancer.
Sponsors: Pfizer, Stemline Therapeutics, Inc., CytomX Therapeutics.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers has 26 clinical trials on record, with 10 currently active. Their work covers Metastatic Renal Cell Carcinoma, Breast Cancer, Metastatic Breast Cancer.
Yes — Rocky Mountain Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.